T&L Co., Ltd.

Equities

A340570

KR7340570001

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-06-09 EDT			5-day change	1st Jan Change
59,800 ^KRW	+8.53%		-0.33%	+49.50%

2023	Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	CI
2023	Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	CI

Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.

June 13, 2023 at 04:45 am

From July 1, 2022 to September 30, 2022, the company has repurchased 13,757 shares, representing 0.17% for KRW 429.53 million. With this, the company has completed the repurchase of 13,757 shares, representing 0.17% for KRW 429.53 million under the buyback announced on June 15, 2022.

Latest news about T&L Co., Ltd.

Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	23-06-13	CI
Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	23-06-13	CI
Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	23-06-13	CI
Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	23-06-13	CI
Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	23-06-13	CI
T&L Co., Ltd.'s Equity Buyback announced on June 15, 2022, has expired with 55,989 shares, representing 0.69% for KRW 1,878.89 million.	23-06-12	CI
T&L Co., Ltd.'s Equity Buyback Plan Extended till June 13, 2023.	22-12-12	CI
T&L Co., Ltd. announces an Equity Buyback for KRW 10,000 million worth of its shares.	22-06-14	CI
T&L Co., Ltd. authorizes a Buyback Plan.	22-06-14	CI
T&L Co., Ltd.(KOSDAQ:A340570) added to S&P Global BMI Index	21-09-20	CI
1,388,000 Common Stock of T&L Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-JUN-2021.	21-06-19	CI
24,000 Common Stock of T&L Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-MAR-2021.	21-03-19	CI
T&L Co., Ltd. has completed an IPO in the amount of KRW 28.8 billion.	20-11-16	CI
T&L Co., Ltd. has filed an IPO.	20-04-28	CI

Chart T&L Co., Ltd.

Duration

Period

More charts

Company Profile

T&L Co Ltd is a Korea-based company engaged in the manufacture and sale of wound treatment materials. The Company's main products include wound treatment materials, orthopedic fixing materials, structural adhesives, and water repellents. The wound treatment materials include products such as hydrocolloids, foams, and hydrogels as wetting dressing agents necessary for wound healing. The orthopedic fixture materials include medical devices used for the treatment and correction of fractures such as casts and splints. The company sells its products in domestic and overseas markets such as the United States, Germany, China, and Dubai.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-08 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for T&L Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

59,800 KRW

Average target price

81,000 KRW

Spread / Average Target

+35.45%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
T&L CO., LTD.	+49.50%	351M
ABBOTT LABORATORIES	-2.34%	187B
MEDTRONIC PLC	+0.92%	109B
BECTON, DICKINSON AND COMPANY	-1.77%	69.22B
CENCORA, INC.	+14.21%	46.19B
DEXCOM, INC.	-6.06%	46.36B
HOYA CORPORATION	+8.48%	42.44B
METTLER-TOLEDO INTERNATIONAL, INC.	+19.03%	30.84B
TERUMO CORPORATION	+19.69%	25.73B
ZIMMER BIOMET HOLDINGS, INC.	-7.25%	23.22B

Other Medical Equipment, Supplies & Distribution